Patient’s immune status associated with outcome following third-generation CAR T-cell therapy – Medical Xpress
|
Patient's immune status associated with outcome following third-generation CAR T-cell therapy
Medical Xpress Treatment with third-generation CAR T–cell therapy led to a complete response in six of 15 patients with a CD19-positive B-cell malignancy and overall survival was associated with the patient's immune status, according to data from a phase I/IIa … |
